

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | indole-containing compound catabolic process (GO:0042436) | 4.72048693 |
| 2 | indolalkylamine catabolic process (GO:0046218) | 4.72048693 |
| 3 | tryptophan catabolic process (GO:0006569) | 4.72048693 |
| 4 | kynurenine metabolic process (GO:0070189) | 4.65904851 |
| 5 | cellular ketone body metabolic process (GO:0046950) | 4.38843918 |
| 6 | regulation of activation of Janus kinase activity (GO:0010533) | 4.18725522 |
| 7 | heme biosynthetic process (GO:0006783) | 4.11716381 |
| 8 | indolalkylamine metabolic process (GO:0006586) | 4.10820360 |
| 9 | ketone body metabolic process (GO:1902224) | 3.91342291 |
| 10 | heme metabolic process (GO:0042168) | 3.87922035 |
| 11 | tryptophan metabolic process (GO:0006568) | 3.80798554 |
| 12 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.73487516 |
| 13 | signal peptide processing (GO:0006465) | 3.62065851 |
| 14 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.61722953 |
| 15 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.59369793 |
| 16 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.53099316 |
| 17 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.51941716 |
| 18 | negative regulation of multicellular organism growth (GO:0040015) | 3.49443865 |
| 19 | amino acid salvage (GO:0043102) | 3.49387908 |
| 20 | L-methionine salvage (GO:0071267) | 3.49387908 |
| 21 | L-methionine biosynthetic process (GO:0071265) | 3.49387908 |
| 22 | lysine catabolic process (GO:0006554) | 3.47262834 |
| 23 | lysine metabolic process (GO:0006553) | 3.47262834 |
| 24 | natural killer cell mediated immunity (GO:0002228) | 3.39397489 |
| 25 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.39397489 |
| 26 | bile acid biosynthetic process (GO:0006699) | 3.38905326 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 3.35934363 |
| 28 | porphyrin-containing compound metabolic process (GO:0006778) | 3.29748075 |
| 29 | indole-containing compound metabolic process (GO:0042430) | 3.28397039 |
| 30 | respiratory chain complex IV assembly (GO:0008535) | 3.24858447 |
| 31 | protein complex biogenesis (GO:0070271) | 3.23875864 |
| 32 | cysteine metabolic process (GO:0006534) | 3.21605512 |
| 33 | sex differentiation (GO:0007548) | 3.19621174 |
| 34 | tetrapyrrole biosynthetic process (GO:0033014) | 3.16811957 |
| 35 | positive regulation of interferon-alpha production (GO:0032727) | 3.14319728 |
| 36 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.13910702 |
| 37 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.11730182 |
| 38 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.07553751 |
| 39 | NADH dehydrogenase complex assembly (GO:0010257) | 3.07553751 |
| 40 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.07553751 |
| 41 | cellular biogenic amine catabolic process (GO:0042402) | 3.06165740 |
| 42 | amine catabolic process (GO:0009310) | 3.06165740 |
| 43 | behavioral response to nicotine (GO:0035095) | 3.03949256 |
| 44 | DNA deamination (GO:0045006) | 3.03141622 |
| 45 | benzene-containing compound metabolic process (GO:0042537) | 3.02617480 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99231238 |
| 47 | photoreceptor cell maintenance (GO:0045494) | 2.98899616 |
| 48 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.98823528 |
| 49 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.97959573 |
| 50 | detection of light stimulus involved in visual perception (GO:0050908) | 2.97959573 |
| 51 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.97741446 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 2.97733542 |
| 53 | low-density lipoprotein particle clearance (GO:0034383) | 2.95239038 |
| 54 | natural killer cell differentiation (GO:0001779) | 2.94651797 |
| 55 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.94468771 |
| 56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93372346 |
| 57 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93125326 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.91987960 |
| 59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91987960 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 2.91614459 |
| 61 | regulation of interferon-alpha production (GO:0032647) | 2.91063541 |
| 62 | intraciliary transport (GO:0042073) | 2.89536566 |
| 63 | regulation of hexokinase activity (GO:1903299) | 2.87941950 |
| 64 | regulation of glucokinase activity (GO:0033131) | 2.87941950 |
| 65 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.86485329 |
| 66 | response to interferon-beta (GO:0035456) | 2.85238150 |
| 67 | regulation of action potential (GO:0098900) | 2.83976136 |
| 68 | oxidative phosphorylation (GO:0006119) | 2.81034059 |
| 69 | valine metabolic process (GO:0006573) | 2.80060408 |
| 70 | piRNA metabolic process (GO:0034587) | 2.80032063 |
| 71 | serotonin metabolic process (GO:0042428) | 2.79679308 |
| 72 | negative regulation of interleukin-17 production (GO:0032700) | 2.79353860 |
| 73 | positive regulation of activated T cell proliferation (GO:0042104) | 2.79171987 |
| 74 | alpha-linolenic acid metabolic process (GO:0036109) | 2.78321825 |
| 75 | cytochrome complex assembly (GO:0017004) | 2.76916084 |
| 76 | regulation of memory T cell differentiation (GO:0043380) | 2.76910480 |
| 77 | epithelial cilium movement (GO:0003351) | 2.76705192 |
| 78 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.75127367 |
| 79 | regulation of cholesterol storage (GO:0010885) | 2.74929371 |
| 80 | positive regulation of lipid storage (GO:0010884) | 2.74470723 |
| 81 | cellular response to interferon-beta (GO:0035458) | 2.74466300 |
| 82 | cilium movement (GO:0003341) | 2.73758462 |
| 83 | positive regulation of interleukin-12 production (GO:0032735) | 2.73437079 |
| 84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.72782921 |
| 85 | reflex (GO:0060004) | 2.71837541 |
| 86 | aspartate family amino acid catabolic process (GO:0009068) | 2.71655175 |
| 87 | T-helper 1 type immune response (GO:0042088) | 2.70604182 |
| 88 | aromatic amino acid family metabolic process (GO:0009072) | 2.70353197 |
| 89 | drug catabolic process (GO:0042737) | 2.69095192 |
| 90 | protein localization to cilium (GO:0061512) | 2.68281141 |
| 91 | nonmotile primary cilium assembly (GO:0035058) | 2.65838367 |
| 92 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.65753285 |
| 93 | aldehyde catabolic process (GO:0046185) | 2.65349923 |
| 94 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.65225536 |
| 95 | folic acid metabolic process (GO:0046655) | 2.63005877 |
| 96 | methionine biosynthetic process (GO:0009086) | 2.62950598 |
| 97 | primary amino compound metabolic process (GO:1901160) | 2.62397328 |
| 98 | cilium morphogenesis (GO:0060271) | 2.62360744 |
| 99 | regulation of establishment of cell polarity (GO:2000114) | 2.61166477 |
| 100 | dopamine transport (GO:0015872) | 2.59421626 |
| 101 | oxidative demethylation (GO:0070989) | 2.59193922 |
| 102 | peptidyl-histidine modification (GO:0018202) | 2.59175999 |
| 103 | auditory receptor cell stereocilium organization (GO:0060088) | 2.58894948 |
| 104 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57920749 |
| 105 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.57561810 |
| 106 | branched-chain amino acid catabolic process (GO:0009083) | 2.57022949 |
| 107 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.56631322 |
| 108 | cofactor catabolic process (GO:0051187) | 2.56075615 |
| 109 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.55668594 |
| 110 | regulation of immune response to tumor cell (GO:0002837) | 2.55564395 |
| 111 | regulation of response to tumor cell (GO:0002834) | 2.55564395 |
| 112 | positive regulation of response to tumor cell (GO:0002836) | 2.55564395 |
| 113 | positive regulation of immune response to tumor cell (GO:0002839) | 2.55564395 |
| 114 | C4-dicarboxylate transport (GO:0015740) | 2.55096044 |
| 115 | ribosomal small subunit assembly (GO:0000028) | 2.54523481 |
| 116 | regulation of RIG-I signaling pathway (GO:0039535) | 2.53873021 |
| 117 | retinal cone cell development (GO:0046549) | 2.53842726 |
| 118 | sterol catabolic process (GO:0016127) | 2.53458398 |
| 119 | cholesterol catabolic process (GO:0006707) | 2.53458398 |
| 120 | flavonoid metabolic process (GO:0009812) | 2.53277411 |
| 121 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.52356903 |
| 122 | DNA double-strand break processing (GO:0000729) | 2.50992397 |
| 123 | sexual reproduction (GO:0019953) | 2.50322693 |
| 124 | 2-oxoglutarate metabolic process (GO:0006103) | 2.49455919 |
| 125 | protein autoprocessing (GO:0016540) | 2.47445690 |
| 126 | nucleoside salvage (GO:0043174) | 2.46135095 |
| 127 | amino-acid betaine metabolic process (GO:0006577) | 2.46078659 |
| 128 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45675734 |
| 129 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.45639192 |
| 130 | ATP synthesis coupled proton transport (GO:0015986) | 2.45639192 |
| 131 | uronic acid metabolic process (GO:0006063) | 2.45574998 |
| 132 | glucuronate metabolic process (GO:0019585) | 2.45574998 |
| 133 | plasma lipoprotein particle clearance (GO:0034381) | 2.45300183 |
| 134 | exogenous drug catabolic process (GO:0042738) | 2.45171293 |
| 135 | behavioral response to ethanol (GO:0048149) | 2.45079511 |
| 136 | glyoxylate metabolic process (GO:0046487) | 2.44918325 |
| 137 | negative regulation of mast cell activation (GO:0033004) | 2.44754028 |
| 138 | righting reflex (GO:0060013) | 2.44567214 |
| 139 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.43977177 |
| 140 | cilium organization (GO:0044782) | 2.43659098 |
| 141 | ethanol oxidation (GO:0006069) | 2.43330970 |
| 142 | neuronal action potential propagation (GO:0019227) | 2.43048113 |
| 143 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.42290889 |
| 144 | response to nitrosative stress (GO:0051409) | 2.41647886 |
| 145 | cellular glucuronidation (GO:0052695) | 2.41566965 |
| 146 | oxaloacetate metabolic process (GO:0006107) | 2.41204912 |
| 147 | cellular response to virus (GO:0098586) | 2.40807120 |
| 148 | cilium assembly (GO:0042384) | 2.40030107 |
| 149 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.40026685 |
| 150 | sulfation (GO:0051923) | 2.39683698 |
| 151 | tricarboxylic acid cycle (GO:0006099) | 2.38985640 |
| 152 | positive regulation of type 2 immune response (GO:0002830) | 2.38354550 |
| 153 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.37491510 |
| 154 | positive regulation of interleukin-17 production (GO:0032740) | 2.37476035 |
| 155 | response to thyroid hormone (GO:0097066) | 2.36555239 |
| 156 | L-phenylalanine metabolic process (GO:0006558) | 2.36416637 |
| 157 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.36416637 |
| 158 | negative regulation of sterol transport (GO:0032372) | 2.36396799 |
| 159 | negative regulation of cholesterol transport (GO:0032375) | 2.36396799 |
| 160 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.36004845 |
| 161 | axoneme assembly (GO:0035082) | 2.35979459 |
| 162 | platelet dense granule organization (GO:0060155) | 2.35792287 |
| 163 | neuronal action potential (GO:0019228) | 2.34657028 |
| 164 | response to interferon-alpha (GO:0035455) | 2.34461500 |
| 165 | carnitine metabolic process (GO:0009437) | 2.34394500 |
| 166 | tachykinin receptor signaling pathway (GO:0007217) | 2.34302519 |
| 167 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.34120199 |
| 168 | glutathione derivative metabolic process (GO:1901685) | 2.33633157 |
| 169 | glutathione derivative biosynthetic process (GO:1901687) | 2.33633157 |
| 170 | electron transport chain (GO:0022900) | 2.33221027 |
| 171 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.33019410 |
| 172 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.32606585 |
| 173 | termination of RNA polymerase III transcription (GO:0006386) | 2.32416544 |
| 174 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.32416544 |
| 175 | L-fucose catabolic process (GO:0042355) | 2.31164341 |
| 176 | fucose catabolic process (GO:0019317) | 2.31164341 |
| 177 | L-fucose metabolic process (GO:0042354) | 2.31164341 |
| 178 | lipid particle organization (GO:0034389) | 2.31104419 |
| 179 | dicarboxylic acid catabolic process (GO:0043649) | 2.31033014 |
| 180 | estrogen biosynthetic process (GO:0006703) | 2.30284764 |
| 181 | glycine metabolic process (GO:0006544) | 2.30108300 |
| 182 | respiratory electron transport chain (GO:0022904) | 2.30052250 |
| 183 | mannosylation (GO:0097502) | 2.30018166 |
| 184 | type I interferon signaling pathway (GO:0060337) | 2.29874258 |
| 185 | cellular response to type I interferon (GO:0071357) | 2.29874258 |
| 186 | response to type I interferon (GO:0034340) | 2.29858735 |
| 187 | serine family amino acid biosynthetic process (GO:0009070) | 2.29237849 |
| 188 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.29161606 |
| 189 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.28529842 |
| 190 | myeloid dendritic cell differentiation (GO:0043011) | 2.27541680 |
| 191 | regulation of interleukin-17 production (GO:0032660) | 2.27414974 |
| 192 | regulation of T-helper cell differentiation (GO:0045622) | 2.26570561 |
| 193 | tetrapyrrole metabolic process (GO:0033013) | 2.26539100 |
| 194 | acrosome assembly (GO:0001675) | 2.26297566 |
| 195 | regulation of gene silencing by miRNA (GO:0060964) | 2.25178740 |
| 196 | serine family amino acid metabolic process (GO:0009069) | 2.25016277 |
| 197 | pentose-phosphate shunt (GO:0006098) | 2.23106989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.56523755 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.44914906 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.88843131 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.54911707 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.46684298 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.10457416 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.90155223 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.82934885 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.77918051 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76177232 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.75451106 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.74530896 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.72456489 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.62049777 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.56817861 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.38383314 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36286864 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32369326 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30245355 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.29246133 |
| 21 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.23332042 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 2.19854864 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.19373188 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.18504935 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 2.12441345 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.10657906 |
| 27 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.10530398 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.06388843 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.05444914 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.98740111 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98687278 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.96788593 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.96778231 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.91532773 |
| 35 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.87550326 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.87285773 |
| 37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86210025 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.84588317 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.84300547 |
| 40 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.79144457 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.77077887 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74568468 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70763612 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68572163 |
| 45 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.68292326 |
| 46 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.68169217 |
| 47 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.67947721 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67261110 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66818372 |
| 50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.62058601 |
| 51 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.61322658 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60921991 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60281552 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60121036 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.59202392 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.58692955 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58641170 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.55645568 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.55140307 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54017701 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53741780 |
| 62 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.52393109 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.51611046 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51250863 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51172027 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51172027 |
| 67 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50660134 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50318631 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.49847072 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.49754890 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49202590 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.49038746 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48740559 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47806038 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47493647 |
| 76 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.47130225 |
| 77 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46965606 |
| 78 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.46452014 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46269659 |
| 80 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43493614 |
| 81 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42633704 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42484839 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42198091 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40985181 |
| 85 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40112029 |
| 86 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39105074 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38654980 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38396794 |
| 89 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.38107548 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38040748 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37738444 |
| 92 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.36841479 |
| 93 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36780252 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35279356 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.35279356 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.35181284 |
| 97 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35160127 |
| 98 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.35150257 |
| 99 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34728677 |
| 100 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34033931 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.34009503 |
| 102 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.33921254 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33840774 |
| 104 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32610941 |
| 105 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.32360004 |
| 106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32221505 |
| 107 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32003607 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.30500593 |
| 109 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30243225 |
| 110 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30243225 |
| 111 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29738551 |
| 112 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29453197 |
| 113 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.28615965 |
| 114 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.28371364 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28242055 |
| 116 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.27762879 |
| 117 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.26177041 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25509839 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25251623 |
| 120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24774154 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24120513 |
| 122 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23632265 |
| 123 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.23532932 |
| 124 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23486022 |
| 125 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22920764 |
| 126 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21865184 |
| 127 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21004438 |
| 128 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20881683 |
| 129 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20859508 |
| 130 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19441399 |
| 131 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19409860 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18988696 |
| 133 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18343180 |
| 134 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17341079 |
| 135 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.17272285 |
| 136 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17222758 |
| 137 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16071126 |
| 138 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15979430 |
| 139 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15979430 |
| 140 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15077213 |
| 141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13833341 |
| 142 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13484828 |
| 143 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12975714 |
| 144 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11971429 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 1.11628998 |
| 146 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11568479 |
| 147 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11016996 |
| 148 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09700528 |
| 149 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.09582383 |
| 150 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08883550 |
| 151 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.08792748 |
| 152 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08751602 |
| 153 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08738619 |
| 154 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08281828 |
| 155 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08023577 |
| 156 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07997208 |
| 157 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07977634 |
| 158 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07738181 |
| 159 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.07693073 |
| 160 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06727894 |
| 161 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06619051 |
| 162 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06439235 |
| 163 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.05520836 |
| 164 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05314099 |
| 165 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03435569 |
| 166 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03225010 |
| 167 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.02899211 |
| 168 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02582202 |
| 169 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02232834 |
| 170 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01774590 |
| 171 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01497102 |
| 172 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00651313 |
| 173 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.00456280 |
| 174 | MAF_26560356_Chip-Seq_TH2_Human | 1.00245917 |
| 175 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99955274 |
| 176 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98678038 |
| 177 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98336849 |
| 178 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97815643 |
| 179 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96809469 |
| 180 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96176027 |
| 181 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94807122 |
| 182 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94745939 |
| 183 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93759708 |
| 184 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93531475 |
| 185 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93115156 |
| 186 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92862896 |
| 187 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92559827 |
| 188 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91751920 |
| 189 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.91240196 |
| 190 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91240097 |
| 191 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91136333 |
| 192 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90227731 |
| 193 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89938278 |
| 194 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89411396 |
| 195 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89235327 |
| 196 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88810766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.43550993 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 3.29076291 |
| 3 | MP0009840_abnormal_foam_cell | 3.10620494 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.92782662 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.84801586 |
| 6 | MP0000685_abnormal_immune_system | 2.78078529 |
| 7 | MP0005360_urolithiasis | 2.71251202 |
| 8 | MP0003186_abnormal_redox_activity | 2.57276391 |
| 9 | MP0009785_altered_susceptibility_to | 2.55385253 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.52272503 |
| 11 | MP0002736_abnormal_nociception_after | 2.48461543 |
| 12 | MP0009046_muscle_twitch | 2.43844892 |
| 13 | MP0003011_delayed_dark_adaptation | 2.42931866 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.40799891 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.33832376 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 2.26336697 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.25281578 |
| 18 | MP0003646_muscle_fatigue | 2.25172340 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.24818095 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.12045519 |
| 21 | MP0003436_decreased_susceptibility_to | 2.10791523 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.07146618 |
| 23 | MP0004043_abnormal_pH_regulation | 2.02472250 |
| 24 | MP0009745_abnormal_behavioral_response | 2.00553556 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 2.00468197 |
| 26 | MP0004510_myositis | 2.00393527 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 1.95903541 |
| 28 | MP0005253_abnormal_eye_physiology | 1.91266025 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.89972261 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.89972261 |
| 31 | MP0005083_abnormal_biliary_tract | 1.89874959 |
| 32 | MP0006082_CNS_inflammation | 1.86773657 |
| 33 | MP0004147_increased_porphyrin_level | 1.84846108 |
| 34 | MP0003880_abnormal_central_pattern | 1.82685035 |
| 35 | MP0002938_white_spotting | 1.78738154 |
| 36 | MP0002272_abnormal_nervous_system | 1.78212109 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.77941308 |
| 38 | MP0002102_abnormal_ear_morphology | 1.77393322 |
| 39 | MP0003136_yellow_coat_color | 1.77036921 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76289558 |
| 41 | MP0003718_maternal_effect | 1.74655875 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.73553631 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.72179157 |
| 44 | MP0005025_abnormal_response_to | 1.67819989 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.66572741 |
| 46 | MP0005410_abnormal_fertilization | 1.66415024 |
| 47 | MP0005671_abnormal_response_to | 1.64840928 |
| 48 | MP0001853_heart_inflammation | 1.64734096 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 1.63353924 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.62637721 |
| 51 | MP0008469_abnormal_protein_level | 1.59480616 |
| 52 | MP0001486_abnormal_startle_reflex | 1.58387401 |
| 53 | MP0005332_abnormal_amino_acid | 1.58049315 |
| 54 | MP0000343_altered_response_to | 1.57574868 |
| 55 | MP0001984_abnormal_olfaction | 1.57423832 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.56229083 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.54973538 |
| 58 | MP0008872_abnormal_physiological_respon | 1.52637154 |
| 59 | MP0002064_seizures | 1.52413574 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.51407147 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.49549268 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.48039220 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.44463136 |
| 64 | MP0003787_abnormal_imprinting | 1.42840766 |
| 65 | MP0004130_abnormal_muscle_cell | 1.40623084 |
| 66 | MP0001529_abnormal_vocalization | 1.39704793 |
| 67 | MP0005365_abnormal_bile_salt | 1.38644793 |
| 68 | MP0006054_spinal_hemorrhage | 1.37889515 |
| 69 | MP0000609_abnormal_liver_physiology | 1.36481725 |
| 70 | MP0006292_abnormal_olfactory_placode | 1.36470341 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.36105332 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35461222 |
| 73 | MP0009764_decreased_sensitivity_to | 1.33790284 |
| 74 | MP0006276_abnormal_autonomic_nervous | 1.33473276 |
| 75 | MP0000749_muscle_degeneration | 1.33364874 |
| 76 | MP0005387_immune_system_phenotype | 1.33048436 |
| 77 | MP0001790_abnormal_immune_system | 1.33048436 |
| 78 | MP0002419_abnormal_innate_immunity | 1.32258683 |
| 79 | MP0002572_abnormal_emotion/affect_behav | 1.31771445 |
| 80 | MP0001348_abnormal_lacrimal_gland | 1.30930430 |
| 81 | MP0000427_abnormal_hair_cycle | 1.30689089 |
| 82 | MP0002734_abnormal_mechanical_nocicepti | 1.30411231 |
| 83 | MP0008775_abnormal_heart_ventricle | 1.29942956 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.28053764 |
| 85 | MP0004885_abnormal_endolymph | 1.27743229 |
| 86 | MP0005058_abnormal_lysosome_morphology | 1.27359701 |
| 87 | MP0001986_abnormal_taste_sensitivity | 1.27252639 |
| 88 | MP0002733_abnormal_thermal_nociception | 1.26044198 |
| 89 | MP0000372_irregular_coat_pigmentation | 1.25363390 |
| 90 | MP0003252_abnormal_bile_duct | 1.24910511 |
| 91 | MP0003283_abnormal_digestive_organ | 1.24900117 |
| 92 | MP0003724_increased_susceptibility_to | 1.24822059 |
| 93 | MP0008438_abnormal_cutaneous_collagen | 1.24249431 |
| 94 | MP0002723_abnormal_immune_serum | 1.23735178 |
| 95 | MP0002452_abnormal_antigen_presenting | 1.23147351 |
| 96 | MP0002735_abnormal_chemical_nociception | 1.21847419 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 1.21585628 |
| 98 | MP0001970_abnormal_pain_threshold | 1.20355249 |
| 99 | MP0004270_analgesia | 1.20193383 |
| 100 | MP0002090_abnormal_vision | 1.18158053 |
| 101 | MP0003950_abnormal_plasma_membrane | 1.17926506 |
| 102 | MP0005330_cardiomyopathy | 1.17789434 |
| 103 | MP0002006_tumorigenesis | 1.16766916 |
| 104 | MP0004924_abnormal_behavior | 1.16158349 |
| 105 | MP0005386_behavior/neurological_phenoty | 1.16158349 |
| 106 | MP0001845_abnormal_inflammatory_respons | 1.14573587 |
| 107 | MP0009643_abnormal_urine_homeostasis | 1.13923711 |
| 108 | MP0005464_abnormal_platelet_physiology | 1.13680191 |
| 109 | MP0003635_abnormal_synaptic_transmissio | 1.13111697 |
| 110 | MP0001800_abnormal_humoral_immune | 1.12948115 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 1.12911458 |
| 112 | MP0001764_abnormal_homeostasis | 1.12613647 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 1.12613557 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 1.12144497 |
| 115 | MP0000604_amyloidosis | 1.11085300 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 1.10077413 |
| 117 | MP0002067_abnormal_sensory_capabilities | 1.09777367 |
| 118 | MP0000383_abnormal_hair_follicle | 1.08983015 |
| 119 | MP0009697_abnormal_copulation | 1.07920459 |
| 120 | MP0009780_abnormal_chondrocyte_physiolo | 1.07469345 |
| 121 | MP0003122_maternal_imprinting | 1.07391161 |
| 122 | MP0002234_abnormal_pharynx_morphology | 1.06694608 |
| 123 | MP0004142_abnormal_muscle_tone | 1.06394259 |
| 124 | MP0004947_skin_inflammation | 1.06072738 |
| 125 | MP0001905_abnormal_dopamine_level | 1.05887449 |
| 126 | MP0004145_abnormal_muscle_electrophysio | 1.05647126 |
| 127 | MP0009763_increased_sensitivity_to | 1.04805970 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 1.04783492 |
| 129 | MP0003941_abnormal_skin_development | 1.04001735 |
| 130 | MP0003303_peritoneal_inflammation | 1.03828448 |
| 131 | MP0003195_calcinosis | 1.03751115 |
| 132 | MP0003075_altered_response_to | 1.03119717 |
| 133 | MP0002557_abnormal_social/conspecific_i | 1.02086854 |
| 134 | MP0001533_abnormal_skeleton_physiology | 1.01742444 |
| 135 | MP0004084_abnormal_cardiac_muscle | 1.01481305 |
| 136 | MP0003121_genomic_imprinting | 1.01366395 |
| 137 | MP0001819_abnormal_immune_cell | 1.00635691 |
| 138 | MP0002269_muscular_atrophy | 0.99949114 |
| 139 | MP0005266_abnormal_metabolism | 0.98848395 |
| 140 | MP0002398_abnormal_bone_marrow | 0.98023738 |
| 141 | MP0000598_abnormal_liver_morphology | 0.96957318 |
| 142 | MP0002420_abnormal_adaptive_immunity | 0.96172031 |
| 143 | MP0002909_abnormal_adrenal_gland | 0.94555329 |
| 144 | MP0008058_abnormal_DNA_repair | 0.94174607 |
| 145 | MP0000858_altered_metastatic_potential | 0.93786215 |
| 146 | MP0001666_abnormal_nutrient_absorption | 0.93706856 |
| 147 | MP0010155_abnormal_intestine_physiology | 0.93541552 |
| 148 | MP0003890_abnormal_embryonic-extraembry | 0.93276599 |
| 149 | MP0002229_neurodegeneration | 0.92680192 |
| 150 | MP0005670_abnormal_white_adipose | 0.92423112 |
| 151 | MP0003566_abnormal_cell_adhesion | 0.90628345 |
| 152 | MP0004133_heterotaxia | 0.90076341 |
| 153 | MP0004215_abnormal_myocardial_fiber | 0.89882960 |
| 154 | MP0002163_abnormal_gland_morphology | 0.89806780 |
| 155 | MP0002063_abnormal_learning/memory/cond | 0.89740165 |
| 156 | MP0003633_abnormal_nervous_system | 0.89635149 |
| 157 | MP0002160_abnormal_reproductive_system | 0.89158205 |
| 158 | MP0003693_abnormal_embryo_hatching | 0.89146008 |
| 159 | MP0000689_abnormal_spleen_morphology | 0.88536056 |
| 160 | MP0002653_abnormal_ependyma_morphology | 0.88257131 |
| 161 | MP0002693_abnormal_pancreas_physiology | 0.88222038 |
| 162 | MP0004036_abnormal_muscle_relaxation | 0.88168987 |
| 163 | MP0002751_abnormal_autonomic_nervous | 0.88130148 |
| 164 | MP0000716_abnormal_immune_system | 0.88001940 |
| 165 | MP0005377_hearing/vestibular/ear_phenot | 0.87883145 |
| 166 | MP0003878_abnormal_ear_physiology | 0.87883145 |
| 167 | MP0002429_abnormal_blood_cell | 0.87674868 |
| 168 | MP0002722_abnormal_immune_system | 0.86095156 |
| 169 | MP0002405_respiratory_system_inflammati | 0.84398233 |
| 170 | MP0004957_abnormal_blastocyst_morpholog | 0.83790963 |
| 171 | MP0010307_abnormal_tumor_latency | 0.82078840 |
| 172 | MP0008057_abnormal_DNA_replication | 0.82075104 |
| 173 | MP0005385_cardiovascular_system_phenoty | 0.81806264 |
| 174 | MP0001544_abnormal_cardiovascular_syste | 0.81806264 |
| 175 | MP0005395_other_phenotype | 0.81588403 |
| 176 | MP0005195_abnormal_posterior_eye | 0.81554210 |
| 177 | MP0000230_abnormal_systemic_arterial | 0.80284237 |
| 178 | MP0004087_abnormal_muscle_fiber | 0.79372606 |
| 179 | MP0002132_abnormal_respiratory_system | 0.79229388 |
| 180 | MP0000516_abnormal_urinary_system | 0.79158515 |
| 181 | MP0006035_abnormal_mitochondrial_morpho | 0.77407387 |
| 182 | MP0005376_homeostasis/metabolism_phenot | 0.72812647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.23671432 |
| 2 | Pancreatic cysts (HP:0001737) | 4.15088149 |
| 3 | Genetic anticipation (HP:0003743) | 3.82439967 |
| 4 | Gaze-evoked nystagmus (HP:0000640) | 3.78772324 |
| 5 | Pancreatic fibrosis (HP:0100732) | 3.78525855 |
| 6 | Increased serum ferritin (HP:0003281) | 3.75921827 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.71775296 |
| 8 | Medial flaring of the eyebrow (HP:0010747) | 3.48836313 |
| 9 | True hermaphroditism (HP:0010459) | 3.47630166 |
| 10 | Abnormality of midbrain morphology (HP:0002418) | 3.25647854 |
| 11 | Molar tooth sign on MRI (HP:0002419) | 3.25647854 |
| 12 | Abnormality of iron homeostasis (HP:0011031) | 3.22502686 |
| 13 | Hyperventilation (HP:0002883) | 3.20878142 |
| 14 | Nausea (HP:0002018) | 3.17540428 |
| 15 | Nephronophthisis (HP:0000090) | 3.15723983 |
| 16 | Abnormal number of erythroid precursors (HP:0012131) | 3.08074175 |
| 17 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.07035993 |
| 18 | Polycythemia (HP:0001901) | 3.03698472 |
| 19 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.00867166 |
| 20 | Reticulocytosis (HP:0001923) | 3.00426627 |
| 21 | Action tremor (HP:0002345) | 2.99593772 |
| 22 | Hyperammonemia (HP:0001987) | 2.98568759 |
| 23 | Petechiae (HP:0000967) | 2.91616553 |
| 24 | Xanthomatosis (HP:0000991) | 2.91579107 |
| 25 | Tetraparesis (HP:0002273) | 2.88585411 |
| 26 | Rhabdomyolysis (HP:0003201) | 2.86948007 |
| 27 | Progressive macrocephaly (HP:0004481) | 2.85496211 |
| 28 | Gait imbalance (HP:0002141) | 2.84308674 |
| 29 | Focal seizures (HP:0007359) | 2.83290037 |
| 30 | Poikilocytosis (HP:0004447) | 2.81178356 |
| 31 | Dialeptic seizures (HP:0011146) | 2.80020648 |
| 32 | Congenital primary aphakia (HP:0007707) | 2.79078684 |
| 33 | Myoglobinuria (HP:0002913) | 2.76511951 |
| 34 | Absence seizures (HP:0002121) | 2.75905579 |
| 35 | Methylmalonic acidemia (HP:0002912) | 2.73356450 |
| 36 | Pendular nystagmus (HP:0012043) | 2.73194579 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 2.70022597 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 2.69216497 |
| 39 | Focal motor seizures (HP:0011153) | 2.69127650 |
| 40 | Nasal polyposis (HP:0100582) | 2.66704892 |
| 41 | Febrile seizures (HP:0002373) | 2.65570186 |
| 42 | Abnormality of the renal medulla (HP:0100957) | 2.65449629 |
| 43 | Cystic liver disease (HP:0006706) | 2.61809311 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.61568215 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.61091395 |
| 46 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.61091395 |
| 47 | Multiple enchondromatosis (HP:0005701) | 2.59684941 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.55578319 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55017341 |
| 50 | Sclerocornea (HP:0000647) | 2.53273769 |
| 51 | Ketoacidosis (HP:0001993) | 2.52997848 |
| 52 | Global brain atrophy (HP:0002283) | 2.52529307 |
| 53 | Nephrogenic diabetes insipidus (HP:0009806) | 2.52405979 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.51991329 |
| 55 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.50549549 |
| 56 | Abolished electroretinogram (ERG) (HP:0000550) | 2.50229628 |
| 57 | Hepatic necrosis (HP:0002605) | 2.49988533 |
| 58 | Acanthocytosis (HP:0001927) | 2.49348779 |
| 59 | Exercise-induced muscle cramps (HP:0003710) | 2.48459080 |
| 60 | Cerebral edema (HP:0002181) | 2.45840717 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45149635 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.44236573 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44236573 |
| 64 | Abnormality of reticulocytes (HP:0004312) | 2.43888773 |
| 65 | Methylmalonic aciduria (HP:0012120) | 2.43290688 |
| 66 | Large for gestational age (HP:0001520) | 2.42796755 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.39878870 |
| 68 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38179671 |
| 69 | Acute encephalopathy (HP:0006846) | 2.37616846 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 2.36163513 |
| 71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.35219926 |
| 72 | Hyperglycinuria (HP:0003108) | 2.35093801 |
| 73 | Genital tract atresia (HP:0001827) | 2.34816272 |
| 74 | Deep venous thrombosis (HP:0002625) | 2.33367682 |
| 75 | Axonal loss (HP:0003447) | 2.32845135 |
| 76 | Abnormality of the Achilles tendon (HP:0005109) | 2.32076866 |
| 77 | Acute necrotizing encephalopathy (HP:0006965) | 2.30713925 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.29276925 |
| 79 | Abnormality of macrophages (HP:0004311) | 2.28513999 |
| 80 | Vaginal atresia (HP:0000148) | 2.28502953 |
| 81 | Inability to walk (HP:0002540) | 2.28469963 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.28145081 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.28145081 |
| 84 | Hepatocellular necrosis (HP:0001404) | 2.27487850 |
| 85 | Vertebral compression fractures (HP:0002953) | 2.26828660 |
| 86 | Cholelithiasis (HP:0001081) | 2.26579022 |
| 87 | Hypothermia (HP:0002045) | 2.26196793 |
| 88 | Myocardial infarction (HP:0001658) | 2.23444455 |
| 89 | Congenital stationary night blindness (HP:0007642) | 2.22934909 |
| 90 | Hypobetalipoproteinemia (HP:0003563) | 2.22260338 |
| 91 | Abnormal ciliary motility (HP:0012262) | 2.22126999 |
| 92 | Dysmetric saccades (HP:0000641) | 2.20946199 |
| 93 | Keratoconus (HP:0000563) | 2.20034742 |
| 94 | Increased corneal curvature (HP:0100692) | 2.20034742 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 2.18846778 |
| 96 | Bile duct proliferation (HP:0001408) | 2.18734078 |
| 97 | Abnormal biliary tract physiology (HP:0012439) | 2.18734078 |
| 98 | Purpura (HP:0000979) | 2.18433641 |
| 99 | Achilles tendon contracture (HP:0001771) | 2.18382456 |
| 100 | Abnormality of the labia minora (HP:0012880) | 2.17512380 |
| 101 | Recurrent bacterial skin infections (HP:0005406) | 2.17477975 |
| 102 | Ketosis (HP:0001946) | 2.17024943 |
| 103 | Esophageal neoplasm (HP:0100751) | 2.16257990 |
| 104 | Neoplasm of head and neck (HP:0012288) | 2.16257990 |
| 105 | Increased IgM level (HP:0003496) | 2.15724737 |
| 106 | Orchitis (HP:0100796) | 2.15572366 |
| 107 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15165440 |
| 108 | Abnormality of glycine metabolism (HP:0010895) | 2.15165440 |
| 109 | Lethargy (HP:0001254) | 2.14773239 |
| 110 | Type II lissencephaly (HP:0007260) | 2.14064862 |
| 111 | Abnormality of macular pigmentation (HP:0008002) | 2.13593750 |
| 112 | Abnormality of alanine metabolism (HP:0010916) | 2.13001307 |
| 113 | Hyperalaninemia (HP:0003348) | 2.13001307 |
| 114 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.13001307 |
| 115 | Hypoalphalipoproteinemia (HP:0003233) | 2.11320827 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 2.10041870 |
| 117 | Poor head control (HP:0002421) | 2.09551118 |
| 118 | Hypoglycemic coma (HP:0001325) | 2.08384964 |
| 119 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.07973925 |
| 120 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07320993 |
| 121 | Hypolipoproteinemia (HP:0010981) | 2.07250544 |
| 122 | Hypertriglyceridemia (HP:0002155) | 2.05035929 |
| 123 | Spastic diplegia (HP:0001264) | 2.04813880 |
| 124 | Mitochondrial inheritance (HP:0001427) | 2.04699610 |
| 125 | Diaphragmatic weakness (HP:0009113) | 2.04362041 |
| 126 | Prostate neoplasm (HP:0100787) | 2.03855926 |
| 127 | Complement deficiency (HP:0004431) | 2.03853094 |
| 128 | Tubular atrophy (HP:0000092) | 2.03143666 |
| 129 | Osteolytic defects of the hand bones (HP:0009699) | 2.02987097 |
| 130 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02987097 |
| 131 | Increased CSF lactate (HP:0002490) | 2.02605518 |
| 132 | Hyperglycinemia (HP:0002154) | 2.02497933 |
| 133 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02204493 |
| 134 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.01210968 |
| 135 | Amyloidosis (HP:0011034) | 2.00966982 |
| 136 | Chronic otitis media (HP:0000389) | 1.99957438 |
| 137 | Furrowed tongue (HP:0000221) | 1.99258973 |
| 138 | CNS demyelination (HP:0007305) | 1.99149713 |
| 139 | Renal cortical cysts (HP:0000803) | 1.98720566 |
| 140 | Lactic acidosis (HP:0003128) | 1.98414081 |
| 141 | Fair hair (HP:0002286) | 1.98207292 |
| 142 | Progressive inability to walk (HP:0002505) | 1.97744553 |
| 143 | Polydipsia (HP:0001959) | 1.96728081 |
| 144 | Abnormal drinking behavior (HP:0030082) | 1.96728081 |
| 145 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96718572 |
| 146 | Myositis (HP:0100614) | 1.96583277 |
| 147 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96387893 |
| 148 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.96302024 |
| 149 | Metabolic acidosis (HP:0001942) | 1.95511334 |
| 150 | Protruding tongue (HP:0010808) | 1.95506878 |
| 151 | Proximal tubulopathy (HP:0000114) | 1.95490189 |
| 152 | Vomiting (HP:0002013) | 1.95466628 |
| 153 | Spontaneous abortion (HP:0005268) | 1.93303238 |
| 154 | Abnormal gallbladder morphology (HP:0012437) | 1.92368786 |
| 155 | Atonic seizures (HP:0010819) | 1.91915430 |
| 156 | Absent speech (HP:0001344) | 1.91456315 |
| 157 | Congenital, generalized hypertrichosis (HP:0004540) | 1.91435803 |
| 158 | Hemiparesis (HP:0001269) | 1.91280592 |
| 159 | Abnormal gallbladder physiology (HP:0012438) | 1.90829098 |
| 160 | Cholecystitis (HP:0001082) | 1.90829098 |
| 161 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.90773380 |
| 162 | Abnormality of vitamin B metabolism (HP:0004340) | 1.90676042 |
| 163 | Attenuation of retinal blood vessels (HP:0007843) | 1.90620907 |
| 164 | Anorexia (HP:0002039) | 1.90611836 |
| 165 | Urticaria (HP:0001025) | 1.90542110 |
| 166 | Male pseudohermaphroditism (HP:0000037) | 1.89801745 |
| 167 | Intestinal atresia (HP:0011100) | 1.89588442 |
| 168 | Respiratory failure (HP:0002878) | 1.89429905 |
| 169 | Thrombophlebitis (HP:0004418) | 1.89256538 |
| 170 | Vascular calcification (HP:0004934) | 1.89173346 |
| 171 | Thrombocytosis (HP:0001894) | 1.88502949 |
| 172 | Retinitis pigmentosa (HP:0000510) | 1.88462026 |
| 173 | Abnormality of the basal ganglia (HP:0002134) | 1.88189495 |
| 174 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87671079 |
| 175 | Absent/shortened dynein arms (HP:0200106) | 1.87671079 |
| 176 | Congenital hepatic fibrosis (HP:0002612) | 1.84845092 |
| 177 | Poor coordination (HP:0002370) | 1.84381643 |
| 178 | Anencephaly (HP:0002323) | 1.83905490 |
| 179 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83098685 |
| 180 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.82800558 |
| 181 | Broad-based gait (HP:0002136) | 1.80367409 |
| 182 | Clumsiness (HP:0002312) | 1.79576857 |
| 183 | Abnormal protein glycosylation (HP:0012346) | 1.79486131 |
| 184 | Abnormal glycosylation (HP:0012345) | 1.79486131 |
| 185 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.79486131 |
| 186 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.79486131 |
| 187 | Postaxial foot polydactyly (HP:0001830) | 1.78332751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.18846922 |
| 2 | NME2 | 3.53724749 |
| 3 | BCKDK | 3.10912019 |
| 4 | CDK19 | 3.03316471 |
| 5 | PIM2 | 2.92916691 |
| 6 | TYK2 | 2.87080559 |
| 7 | TBK1 | 2.75195323 |
| 8 | TRIB3 | 2.73854508 |
| 9 | BMPR1B | 2.73429119 |
| 10 | MAP4K2 | 2.70876709 |
| 11 | MAP3K14 | 2.69264660 |
| 12 | OXSR1 | 2.68625090 |
| 13 | PDK4 | 2.54949894 |
| 14 | PDK3 | 2.54949894 |
| 15 | ARAF | 2.46417072 |
| 16 | TESK1 | 2.44338867 |
| 17 | ERN1 | 2.38059344 |
| 18 | ADRBK2 | 2.31158204 |
| 19 | WNK3 | 2.20255398 |
| 20 | CASK | 2.19442197 |
| 21 | NUAK1 | 2.11480312 |
| 22 | IKBKB | 2.09400564 |
| 23 | GRK1 | 2.08838787 |
| 24 | ABL2 | 1.84576988 |
| 25 | PBK | 1.78942667 |
| 26 | STK38L | 1.78725792 |
| 27 | SCYL2 | 1.78716673 |
| 28 | MAP3K11 | 1.75711950 |
| 29 | EIF2AK1 | 1.69824311 |
| 30 | MAP2K3 | 1.68427600 |
| 31 | BUB1 | 1.67897272 |
| 32 | INSRR | 1.62917661 |
| 33 | IKBKE | 1.60302503 |
| 34 | TTN | 1.58410311 |
| 35 | KDR | 1.57464518 |
| 36 | JAK3 | 1.56714796 |
| 37 | PDK2 | 1.54958059 |
| 38 | MAP3K13 | 1.50707460 |
| 39 | NEK1 | 1.48045738 |
| 40 | WEE1 | 1.44958784 |
| 41 | LRRK2 | 1.42503838 |
| 42 | MAPK13 | 1.41397232 |
| 43 | PKN2 | 1.39892672 |
| 44 | PNCK | 1.38550997 |
| 45 | MKNK2 | 1.38124114 |
| 46 | BLK | 1.38018925 |
| 47 | MAP3K4 | 1.36814781 |
| 48 | ZAK | 1.34785080 |
| 49 | ERBB3 | 1.34758950 |
| 50 | MAP4K1 | 1.33422899 |
| 51 | MAP3K10 | 1.29550612 |
| 52 | MAP3K8 | 1.27479901 |
| 53 | ACVR1B | 1.24595844 |
| 54 | RPS6KA4 | 1.17501621 |
| 55 | TNIK | 1.16659714 |
| 56 | TRIM28 | 1.16445542 |
| 57 | EIF2AK3 | 1.16189829 |
| 58 | STK4 | 1.15706420 |
| 59 | RIPK4 | 1.15703991 |
| 60 | JAK1 | 1.13320345 |
| 61 | MAP3K3 | 1.12099948 |
| 62 | PIM1 | 1.11322658 |
| 63 | STK39 | 1.10531254 |
| 64 | MST1R | 1.10494890 |
| 65 | STK16 | 1.09011539 |
| 66 | CSNK1G1 | 1.08885330 |
| 67 | NEK2 | 1.08829940 |
| 68 | VRK2 | 1.08323595 |
| 69 | BMX | 1.07789405 |
| 70 | MUSK | 1.07640585 |
| 71 | NTRK3 | 1.06848070 |
| 72 | CSNK1G2 | 1.06782366 |
| 73 | CHUK | 1.06438924 |
| 74 | PRKCE | 1.04803543 |
| 75 | BCR | 1.04672186 |
| 76 | PHKG2 | 1.04622959 |
| 77 | PHKG1 | 1.04622959 |
| 78 | PRKCG | 1.04424121 |
| 79 | FLT3 | 1.02728170 |
| 80 | BRAF | 1.02066167 |
| 81 | JAK2 | 0.99811754 |
| 82 | WNK4 | 0.98351541 |
| 83 | PAK3 | 0.98134540 |
| 84 | PINK1 | 0.98113514 |
| 85 | STK3 | 0.97760171 |
| 86 | DAPK3 | 0.97618659 |
| 87 | FER | 0.93085512 |
| 88 | CSNK1G3 | 0.92769133 |
| 89 | TESK2 | 0.92627700 |
| 90 | MKNK1 | 0.92540338 |
| 91 | PLK2 | 0.92428645 |
| 92 | NEK9 | 0.92179671 |
| 93 | ZAP70 | 0.86866872 |
| 94 | ADRBK1 | 0.86229557 |
| 95 | ILK | 0.85142305 |
| 96 | DAPK2 | 0.83392264 |
| 97 | PLK3 | 0.83269127 |
| 98 | MARK1 | 0.82290904 |
| 99 | CSNK1A1L | 0.80647040 |
| 100 | RAF1 | 0.77923054 |
| 101 | VRK1 | 0.76347309 |
| 102 | MAP2K7 | 0.75648879 |
| 103 | TIE1 | 0.72072814 |
| 104 | OBSCN | 0.71874162 |
| 105 | SIK1 | 0.70696220 |
| 106 | AKT3 | 0.69095614 |
| 107 | PAK4 | 0.68714870 |
| 108 | STK10 | 0.68555362 |
| 109 | CAMK2A | 0.67729031 |
| 110 | EPHA4 | 0.66713456 |
| 111 | KIT | 0.64965175 |
| 112 | PTK2B | 0.63544100 |
| 113 | TGFBR1 | 0.63521805 |
| 114 | TNK2 | 0.63081332 |
| 115 | FGFR4 | 0.62996980 |
| 116 | CDK4 | 0.62652078 |
| 117 | MYLK | 0.62253270 |
| 118 | TLK1 | 0.61885457 |
| 119 | CSNK1A1 | 0.61817763 |
| 120 | MOS | 0.61794939 |
| 121 | SRPK1 | 0.60259277 |
| 122 | NME1 | 0.60046884 |
| 123 | MAP3K5 | 0.60042998 |
| 124 | MAP3K7 | 0.59778172 |
| 125 | PLK1 | 0.59420084 |
| 126 | MAP2K6 | 0.59108780 |
| 127 | CAMKK2 | 0.58969600 |
| 128 | PTK6 | 0.58743679 |
| 129 | KSR2 | 0.58320373 |
| 130 | MAP2K2 | 0.57747897 |
| 131 | SYK | 0.57204885 |
| 132 | MST4 | 0.53726196 |
| 133 | PIK3CG | 0.53661770 |
| 134 | CDK3 | 0.52654310 |
| 135 | PAK1 | 0.52328546 |
| 136 | DYRK2 | 0.52216893 |
| 137 | PRKAA2 | 0.51354001 |
| 138 | MAPK12 | 0.48362294 |
| 139 | FGFR2 | 0.47723145 |
| 140 | BMPR2 | 0.47087846 |
| 141 | PRKACA | 0.46244622 |
| 142 | MAPKAPK5 | 0.44438123 |
| 143 | TGFBR2 | 0.44099971 |
| 144 | TAOK2 | 0.43140277 |
| 145 | CAMK2D | 0.42623780 |
| 146 | LATS1 | 0.42440431 |
| 147 | TEC | 0.41967742 |
| 148 | CAMK1 | 0.41260902 |
| 149 | IRAK3 | 0.40972120 |
| 150 | CDC7 | 0.40299488 |
| 151 | CSF1R | 0.39885217 |
| 152 | CSNK1D | 0.38994804 |
| 153 | PRKG1 | 0.38753205 |
| 154 | STK38 | 0.38537804 |
| 155 | GRK6 | 0.37638929 |
| 156 | PRKACB | 0.37203230 |
| 157 | PKN1 | 0.37172808 |
| 158 | STK11 | 0.36461756 |
| 159 | AKT2 | 0.36455253 |
| 160 | PRKCA | 0.36142765 |
| 161 | GRK5 | 0.35749153 |
| 162 | SGK2 | 0.35321106 |
| 163 | PRKD3 | 0.34693405 |
| 164 | DYRK1A | 0.34637988 |
| 165 | TTK | 0.34625259 |
| 166 | LMTK2 | 0.34480130 |
| 167 | BTK | 0.34455614 |
| 168 | MAPKAPK3 | 0.34339703 |
| 169 | CSNK1E | 0.33881593 |
| 170 | RPS6KA5 | 0.33867530 |
| 171 | BRSK2 | 0.33353501 |
| 172 | MAPKAPK2 | 0.32767094 |
| 173 | TAOK1 | 0.32762246 |
| 174 | MAP2K1 | 0.31716386 |
| 175 | MARK3 | 0.31040568 |
| 176 | DYRK1B | 0.30915029 |
| 177 | TAOK3 | 0.30293945 |
| 178 | CDK6 | 0.29333402 |
| 179 | PRKCD | 0.29120426 |
| 180 | RPS6KA1 | 0.27368152 |
| 181 | AURKB | 0.27331441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25664892 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.72510986 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 2.39467090 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.33209502 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.30396851 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.30354416 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20822888 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14931551 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08410645 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08348294 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.02164853 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00001076 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.99736513 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92523254 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.90441402 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.81056215 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.80833482 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80219790 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.77767109 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74563604 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70349698 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.70023050 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.69222557 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68797142 |
| 25 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.67936756 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58852293 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.58232527 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.54269825 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.54004481 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51631041 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.51251076 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50939171 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.49612631 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.49375608 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.48303245 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.47347799 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41769953 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.41754252 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.39793164 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36646052 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.35710556 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34504727 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33851364 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33849762 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31852531 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31692175 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31036116 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.29590859 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.23436100 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22914021 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21183667 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20667649 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16974748 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15611924 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15385433 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11737256 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 1.07833540 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02813684 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.02497723 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01890566 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01454037 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01198440 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00548656 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00462462 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00359614 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99543011 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99506065 |
| 68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.99167017 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97387829 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96996157 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95942195 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95906844 |
| 73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94561991 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.93508207 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93211104 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92666042 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92645318 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90604357 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90309953 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.87761629 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87349326 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86357579 |
| 83 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85539052 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84896723 |
| 85 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.83687313 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83523511 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82893322 |
| 88 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81959516 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81111684 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79494954 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79126127 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76988172 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76924940 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75805448 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75728169 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75587684 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.75318525 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74008573 |
| 99 | RNA degradation_Homo sapiens_hsa03018 | 0.73881285 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72655230 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72151138 |
| 102 | Morphine addiction_Homo sapiens_hsa05032 | 0.71497845 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69372934 |
| 104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68019811 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67447691 |
| 106 | Measles_Homo sapiens_hsa05162 | 0.67365907 |
| 107 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66964489 |
| 108 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66697116 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65999039 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65943031 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.65554684 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.65251768 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65189081 |
| 114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64817111 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64752605 |
| 116 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63300833 |
| 117 | Circadian entrainment_Homo sapiens_hsa04713 | 0.63225039 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61890611 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.60210377 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.60027187 |
| 121 | * Purine metabolism_Homo sapiens_hsa00230 | 0.59419796 |
| 122 | Base excision repair_Homo sapiens_hsa03410 | 0.58437235 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.58360920 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57713107 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57447709 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55714244 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54571942 |
| 128 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54518373 |
| 129 | Tuberculosis_Homo sapiens_hsa05152 | 0.53924807 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53717651 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52245877 |
| 132 | Mismatch repair_Homo sapiens_hsa03430 | 0.51799335 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51634142 |
| 134 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51234273 |
| 135 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50347149 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50024159 |
| 137 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49961138 |
| 138 | RNA polymerase_Homo sapiens_hsa03020 | 0.48776030 |
| 139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48270886 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45108423 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.44105418 |
| 142 | Long-term depression_Homo sapiens_hsa04730 | 0.43685108 |
| 143 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43109352 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42731021 |
| 145 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42005634 |
| 146 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41235322 |
| 147 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39620811 |
| 148 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37721649 |

